(Q36021497)
Statements
Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24) (English)
W Körner
P Chiba
R Dornetshuber
L Elbling
12 March 2007
1 reference
1 reference
1 reference
1 reference